← Eichor
Study identifier: NCT06647225 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Using Artificial Intelligence to Screen for Hip Dysplasia

Condition: Developmental Dysplasia of Hip  ·  Sponsor: Murdoch Childrens Research Institute

PhaseNA
Planned participants240
Who can joinAll sexes, 4 Weeks to 20 Weeks
Healthy volunteersYes

About this study

The goal of this clinical trial is to learn if an ultrasound scan using artificial intelligence can accurately screen for hip dysplasia. Researchers will compare the artificial intelligence ultrasound results to the standard ultrasound measures to see if the artificial intelligence ultrasound scan can accurately screen for hip dysplasia. It will also seek to understand how parents feel about their children undergoing this scan. Participants will: * Have an additional ultrasound performed on their child at their scheduled outpatient's appointment for hip dysplasia * Complete a short questionnaire about the experience of having the measurement performed on their child

This description comes directly from the study's public registry record.

Talk to the study team

Natalie K Hyde, BBiomedSc (Hons), PhD  ·  61 3 9936 6246  ·  natalie.hyde@mcri.edu.au

Melissa Formosa  ·  melissa.formosa@mcri.edu.au

Always discuss trial participation with your own doctor first.

Locations (1)

Royal Children's HospitalParkville, Victoria, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06647225